Skip to main content

Nonprofit · EIN 86-1024333

THE INTERNATIONAL GENOMICS CONSORTIUM

Tax-exempt · PHOENIX, AZ 85004

Financials

$84K$1.4M2023$281K$1.3M2024
Revenue Expenses · by fiscal year end
Financials of THE INTERNATIONAL GENOMICS CONSORTIUM by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$281,106$1,339,053-$1,057,947$11,870,776$487,297$11,383,479
December 31, 2023990$83,902$1,413,171-$1,329,269$10,812,620$612,192$10,200,428
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$0
Investment income
$110,549
Net rental income
$145,512
Other revenue
$170,557

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$947,676
Salaries, compensation and benefits (total)
$995,853
Professional fundraising fees
$0
Legal fees
$55,333
Accounting fees
$21,950
Occupancy
$132,808
Travel
$984
Program services (functional)
$695,649
Management and general (functional)
$475,044
Fundraising (functional)
$168,360

Balance sheet and other

Total assets, start of year
$10,812,620
Total assets, end of year
$11,870,776
Total liabilities, end of year
$487,297
Net assets, end of year
$11,383,479
Land, buildings and equipment
$127,178
Publicly traded securities
$9,224,700
Net assets without donor restrictions
$11,383,479
Gross receipts
$1,476,371
Employees
3
Volunteers
0
Year formed
2001
State of legal domicile
AZ

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
DAVID MALLERYCEO
Trustee or director, Officer
40$653,519$19,923
SCOTT MORRISCSO
Officer
40$161,645$19,923
VANESA ROMEROCFO
Officer
20$45,042$22,625
TROY SHELTONBOARD MEMBER
Trustee or director
0.5$25,000$0
990 for the year ended December 31, 2023: 4 people
NameTitleHours / weekCompensationOther / benefits
DAVID MALLERYCEO
Trustee or director, Officer
32$600,000$63,981
SCOTT MORRISCSO
Officer
24$141,158$36,451
VANESA ROMEROCFO
Officer
16$40,404$30,405
TROY SHELTONBOARD MEMBER
Trustee or director
0.5$3,000$0

Address and contacts

Address (IRS master file)
850 N 5TH ST STE 400, PHOENIX, AZ 85004-2976
In care of
% DAVID MALLERY
Principal officer (990 for 2024)
DAVID MALLERY, 445 NORTH FIFTH STREET NO 300, PHOENIX, AZ 85004
Signed the 990
VANESA ROMERO, CFO
Phone
(602) 850-7000
Return prepared by
BAKER TILLY ADVISORY GROUP LP

Mission

THE MISSION OF IGC IS TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES BY RIGOROUSLY DEVELOPING AND APPLYING POST-GENOME SCIENCE TO ADVANCES IN HUMAN HEALTH.

990 for the year ended December 31, 2024

Program accomplishments

  • IGC CONTINUES TO BUILD ON THEIR ONGOING RESEARCH COLLABORATIONS WITH A VARIETY OF HOSPITALS INCLUDING WITH SCOTTSDALE HEALTHCARE HOSPITAL (NOW HONORHEALTH) BY PROVIDING ACCESS TO ITS BANKED SPECIMENS WITH CLINICAL DATA GATHERED IN COLLABORATION WITH THE HEALTH CARE CENTERS. THESE ARE REDISTRIBUTED TO SUPPORT A VARIETY OF RESEARCH INCLUDING THE CANCER GENOME ATLAS PROJECT AT THE NATIONAL CANCER INSTITUTE AND FOLLOW ON STUDIES AND DATA ACCESS QUERIES. IGC'S RESEARCH SERVICES UTILIZES THE CLINICAL TRIALS AND ANALYSIS EXPERTISE AS WELL AS THE DATA COLLECTED FROM THEIR HOSPITAL AND CLINICAL COLLABORATORS TO ACCELERATE AND INCUBATE INNOVATIVE RESEARCH PROGRAMS IN WOMEN'S HEALTH, EARLY CANCER DIAGNOSTICS AND TO FIND NEW PATHWAYS FOR INNOVATIVE TREATMENT METHODS. IGC ALSO REFINES THE DATA FROM THE NATIONAL LUNG SCREENING TRIAL (NLST) AT THE NCI TO LEVERAGE THE DATABASE TO IMPACT CLINICAL UTILITY.IGC COLLABORATES WITH PRECISION FOR MEDICIENE TO PROVIDE ACCESS TO IGC'S EXPO SPECIMENS ACROSS THE MOST PREVALANT CANCER TYPES INCLUDING ASSOCIATED CLINICAL DATA AND ANALYSIS.
    Expenses $695,649

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
86-1024333
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2002
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$11,870,776
Income (IRS master file)
$1,476,371

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$281,106$1,339,053$11,870,776IRS
990December 2023$83,902$1,413,171$10,812,620XML
990December 2022$294,190$1,516,541$10,251,570IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 86-1024333).

Questions about THE INTERNATIONAL GENOMICS CONSORTIUM

What is the EIN of THE INTERNATIONAL GENOMICS CONSORTIUM?
The employer identification number (EIN) of THE INTERNATIONAL GENOMICS CONSORTIUM is 86-1024333.
Is THE INTERNATIONAL GENOMICS CONSORTIUM tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2002.
Are donations to THE INTERNATIONAL GENOMICS CONSORTIUM tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does THE INTERNATIONAL GENOMICS CONSORTIUM file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of THE INTERNATIONAL GENOMICS CONSORTIUM due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did THE INTERNATIONAL GENOMICS CONSORTIUM last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of THE INTERNATIONAL GENOMICS CONSORTIUM?
The 990 for the year ended December 31, 2024 names DAVID MALLERY.
Who are the officers and directors of THE INTERNATIONAL GENOMICS CONSORTIUM?
The 990 for the year ended December 31, 2024 lists 4 people; 4 received compensation from the organization, the highest $653,519 (DAVID MALLERY, CEO).
How much revenue does THE INTERNATIONAL GENOMICS CONSORTIUM have?
On its 990 for the year ended December 31, 2024 it reported revenue of $281,106, expenses of $1,339,053 and total assets of $11,870,776 at year end.

Other nonprofits in PHOENIX

All nonprofits in PHOENIX · Arizona · Medical research